Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Saved in:
Bibliographic Details
Main Authors: Papachristofilou, Alexandros (Author) , Sebastian, Martin (Author) , Bischoff, Helge (Author)
Format: Article (Journal) Book/Monograph
Language:English
Published: London BioMed Central 2019
Heidelberg Universitätsbibliothek Heidelberg 2019
DOI:10.1186/s40425-019-0520-5
Online Access:Resolving-System, kostenfrei, Volltext: https://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-260704
Resolving-System, kostenfrei, Volltext: https://doi.org/10.1186/s40425-019-0520-5
Verlag, kostenfrei, Volltext: http://www.ub.uni-heidelberg.de/archiv/26070
Get full text
Author Notes:Alexandros Papachristofilou, Madeleine M. Hipp, Ute Klinkhardt, Martin Früh, Martin Sebastian, Christian Weiss, Miklos Pless, Richard Cathomas, Wolfgang Hilbe, Georg Pall, Thomas Wehler, Jürgen Alt, Helge Bischoff, Michael Geißler, Frank Griesinger, Karl-Josef Kallen, Mariola Fotin-Mleczek, Andreas Schröder, Birgit Scheel, Anke Muth, Tobias Seibel, Claudia Stosnach, Fatma Doener, Henoch S. Hong, Sven D. Koch, Ulrike Gnad-Vogt, Alfred Zippelius
Description
Item Description:In: Journal for ImmunoTherapy of Cancer, 7 (2019), Nr. 38. pp. 1-14. ISSN 2051-1426
Physical Description:Online Resource
DOI:10.1186/s40425-019-0520-5